The impact of LRP4 mutations on hepatocellular carcinoma recurrence and immunotherapy response

1Institute of Innovative Drug Discovery and Development, China Pharmaceutical University, Nanjing, China 2State Key Laboratory of Natural Medicines, Department of Pharmacology, School of Pharmacy, China Pharmaceutical University, Nanjing, China 3State Key Laboratory of Liver Research, Department of Pathology, School of Clinical Medicine, Li Ka Shing Faculty of Medicine, the University of Hong Kong, Hong Kong, China Correspondence Chun-Ming Wong, State Key Laboratory of Liver Research, Rm 711, No. 5 Sassoon Road, the University of Hong Kong, Hong Kong, China. Email: [email protected] Correspondence Zhen Lu, Department of Pharmacology, Institute of Innovative Drug Discovery and Development (IDDD), China Pharmaceutical University. Jiangning Campus: #639 Longmian Dadao, Jiangning District, Nanjing, China, 211198. Email: [email protected]